Marcus, 14,335 patient sleep study: 16% fewer symptomatic cases [p=0.0007] https://c19p.org/marcussl
copied to clipboard
Predictors of incident viral symptoms ascertained in the era of COVID-19
et al., PLOS ONE, doi:10.1371/journal.pone.0253120
Prospective survey based study with 14,335 participants, showing risk of viral symptoms associated with shorter sleep duration.
|
risk of symptomatic case, 16.0% lower, OR 0.84, p < 0.001, adjusted per study, per extra hour sleep, multivariable, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Marcus et al., 6/17/2021, prospective, multiple countries, multiple regions, peer-reviewed, survey, 12 authors, study period 26 March, 2020 - 3 May, 2020.
marcus
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.